Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.48 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.48 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 3/20 | 0.41 |
| ▸ | QDPR | P09417 | 1/20 | 0.41 |
| ▸ | FASN | P49327 | 4/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | MLNR | O43193 | 3/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22324942 | 0.84 | SLC18A3 (0.46) | SLC18A3SIGMAR1HTR2CQDPRNAMPT | |
| SCHEMBL29803716 | 0.82 | MAOA (0.49) | SLC18A3SIGMAR1HTR2CQDPRNAMPT | |
| SCHEMBL19520252 | 0.81 | MEN1 (0.55) | FASNMLNRPDK2 | |
| SCHEMBL4802576 | 0.80 | LMNA (0.49) | HSD17B1HSD17B2FASN | |
| Hydrochloric Acid SCHEMBL19520341 | 0.79 | PDK2 (0.52) | HSD17B1HSD17B2MLNRPDK2 | |
| SCHEMBL31701935 | 0.77 | BRD4 (0.43) | SLC18A3SIGMAR1HTR2CQDPRNAMPT | |
| SCHEMBL1663395 | 0.77 | SLC18A3 (0.55) | SLC18A3SIGMAR1HTR2CQDPR | |
| Hydrochloric Acid SCHEMBL9255650 | 0.75 | SLC18A3 (0.53) | SLC18A3SIGMAR1HTR2CQDPR | |
| SCHEMBL13135281 | 0.75 | FASN (0.48) | HSD17B1HSD17B2FASNMLNRPDK2 | |
| SCHEMBL16994743 | 0.75 | PDK2 (0.58) | HSD17B1HSD17B2FASNPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0673928-B1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI SYNTHELABO (FR) | 2001-08-29 | — | — | EP | disclosed |